0001062993-23-017413.txt : 20230901
0001062993-23-017413.hdr.sgml : 20230901
20230901160632
ACCESSION NUMBER: 0001062993-23-017413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230830
FILED AS OF DATE: 20230901
DATE AS OF CHANGE: 20230901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nusse Roeland
CENTRAL INDEX KEY: 0001492695
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 231232522
MAIL ADDRESS:
STREET 1: 473 TENNESSEE
CITY: PALO ALTO
STATE: CA
ZIP: 94306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-08-30
0000842023
BIO-TECHNE Corp
TECH
0001492695
Nusse Roeland
614 MCKINLEY PL N E
MINNEAPOLIS
MN
55413
1
0
0
0
0
Common Stock
2023-08-30
4
M
0
16000
21.85
A
44811
D
Common Stock
2023-08-30
4
M
0
16000
22.95
A
60811
D
Common Stock
2023-08-30
4
S
0
8939
80.3176
D
51872
D
Stock Options (Right to Buy)
21.85
2023-08-30
4
M
0
16000
0
D
2013-10-31
2023-10-30
Common Stock
16000
0
D
Stock Options (Right to Buy)
22.95
2023-08-30
4
M
0
16000
0
D
2014-10-30
2024-10-30
Common Stock
16000
0
D
Stock Options (Right to Buy)
21.84
2016-10-29
2025-10-28
Common Stock
17040
17040
D
Stock Options (Right to Buy)
25.30
2017-10-26
2026-10-27
Common Stock
15940
15940
D
Stock Options (Right to Buy)
31.26
2018-10-25
2027-10-26
Common Stock
12500
12500
D
Stock Options (Right to Buy)
44.96
2019-10-24
2028-10-25
Commo Stock
7592
7592
D
Stock Options (Right to Buy)
50.41
2020-10-24
2029-10-24
Common Stock
8044
8044
D
Stock Options (Right to Buy)
63.92
2021-10-28
2030-10-29
Common Stock
6028
6028
D
Stock Options (Right to Buy)
128.81
2022-10-27
2031-10-28
Common Stock
2532
2532
D
Stock Options (Right to Buy)
73.94
2032-10-27
Common Stock
3460
3460
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.09 to $80.78, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.
Andrew Nick as Attorney-in-Fact for Roeland Nusse pursuant to Power of Attorney previously filed
2023-09-01